Structure-based design of I-BET778: a BD1 selective BET inhibitor

William Kerr, Christopher Wellaway

Research output: Contribution to conferenceSpeech

Original languageEnglish
Publication statusPublished - 23 Jul 2014
Event4th GSK/University of Strathclyde MPhil/PhD Symposium - GlaxoSmithKline Medicines Research Centre, Stevenage, United Kingdom
Duration: 23 Jul 201423 Jul 2014

Conference

Conference4th GSK/University of Strathclyde MPhil/PhD Symposium
CountryUnited Kingdom
CityStevenage
Period23/07/1423/07/14

Keywords

  • structure based design
  • BET inhibitors
  • bromodomain
  • extra-terminal proteins

Cite this